Joe Kelly Email & Phone Number

Hellerup, Capital Region Of Denmark, DK

• I stepped into this role to strengthen and scale the company’s business and commercial functions. My focus: to drive alignment across sales, marketing, medical affairs, regulatory, legal, and compliance—laying a strong.
• Build out a robust, scalable infrastructure enabling the launch of Yorvipath, a flagship FDA-approved drug for hypoparathyroidism.
• Adopt a forward-looking, growth-centric business plan and commercial strategy to position Ascendis as a leading name in rare endocrine therapies.

Hellerup, Capital Region Of Denmark, DK

• Established the company’s specialty sales team (30 employees) from the ground up as VP of Sales. From there, I advanced to new positions—shaping strategy, defining and educating the market, and influencing a paradigm.
• Built the sales and commercial function for pre- and post-approval success.
• Steered the company’s first-ever launch: Skytrofa for children with growth hormone deficiency.
• Led Skytrofa to become the overall value leader in its category, within 18 months of launch.

Boston, MA, US

• Joined Radius Health to provide commercial vision and leadership seven months after the launch of the company’s first product TYMLOS for osteoporosis. As a key member of the executive team, I owned P&L and directed.
• Revamped the commercial function and revised the sales footprint to jumpstart performance in the specialty market.
• Energized the culture and realigned the team—hiring top talent and embedding a growth mindset into daily operations.
• Influenced commercial strategy for two molecules in the oncology development pipeline.

Bagsværd, DK

• Provided strategic direction and established a growth trajectory across two distinct regions—generating over $1B in annual sales. I developed and executed business plans, restructured operations, revitalized teams, and.
• Increased sales of Victoza GLP-1, Levemir, and Tresiba insulin—achieving top rankings companywide.
• Partnered with the President of Novo Nordisk US to grow the business over the long term.
• Targeted and engaged hard-to-reach customers through tech advancements and digital campaigns.

Bagsværd, DK

Novo Nordisk’s Political Action CommitteeBoard Member2013 to Present

Bagsværd, DK

In my role as Senior Institutional Business Director, pioneered and executed strategies to improve institutional sales performance. Together with my team, I strengthened relationships, navigated industry complexities, and closed high-value deals.✓ Positioned Levemir® as basal insulin market leader, dominating market share held by a competitor for 12.

Bagsværd, DK

In 2013, I traveled to Copenhagen and Zurich to work with Novo Nordisk’s corporate marketing team in developing an institutional sales framework for the global organization.✓ Presented sales framework project at Novo Nordisk’s Global Sales Forum in 2014.✓ Gained senior executive approval and buy-in prior to program launch across China, France, Japan, and.

Bagsværd, DK

Based on proven performance as a sales and business leader, I was selected to turn around the under-producing Florida / Puerto Rico region. Through placing the right people in the right roles and coaching for top performance, the team was energized for superior performance and morale.✓ Transformed the region from bottom 20% to reach #5 nationally in 12.

Bagsværd, DK

I earned a series of promotions for rapid, steady sales performance. My teams and I developed relationships with endocrinologists, primary care physicians, and diabetes care specialists in hospitals and medical practices, and promoted products across all sales channels.✓ Marketed and sold InnoLet®, NovoLog®, Levemir® and NovoLog Mix 70/30® to.

Los Angeles, California, US

Education record

Education record